CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
FCL+BPS +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05528770
NCT05528770N/ACompleted
CompareCT.gov

Evaluation of The Postprandial Impact of Automated Priming Bolus for Full Closed Loop Insulin Delivery

Marc Breton·interventional·Posted Sep 6, 2022·Updated Sep 8, 2025

In Brief

A clinical study evaluating FCL+BPS and FCL for Type 1 Diabetes. Completed, enrolled 15 participants across 1 site.

Detailed Summary

The purpose of this study is to understand the impact of the automated priming boluses on the safety and feasibility of a new fully automated AP controller.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
CollaboratorsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

N/ACompletedFinished
2023202420252026
First PostedSep 6, 2022
Enrollment StartOct 20, 2022
Primary CompletionJan 13, 2023
Study CompletionJan 15, 2023
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 3.8 years ago

Interventions

FCL+BPSdevice

The automated insulin delivery system includes the Bolus Priming System, a software automatically analyzing past continuous glucose monitoring values to trigger priming insulin bolus delivery isn the suspected presence of meal like glycemic disturbances

FCLdevice

The automated insulin delivery system does not include the Bolus Priming System, and therefore does not automatically command priming boluses.